![Biomedicines | Free Full-Text | CAR T-Based Therapies in Lymphoma: A Review of Current Practice and Perspectives Biomedicines | Free Full-Text | CAR T-Based Therapies in Lymphoma: A Review of Current Practice and Perspectives](https://pub.mdpi-res.com/biomedicines/biomedicines-10-01960/article_deploy/html/images/biomedicines-10-01960-ag.png?1661273190)
Biomedicines | Free Full-Text | CAR T-Based Therapies in Lymphoma: A Review of Current Practice and Perspectives
![Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and](https://www.astctjournal.org/cms/attachment/719261ae-31b8-4b05-b3a3-feba082cd05a/gr2_lrg.jpg)
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
![Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy - Biology of Blood and Marrow Transplantation Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/aab11966-4fa7-4084-9ffc-be81504bfee5/gr1.jpg)
Understanding and Managing Large B Cell Lymphoma Relapses after Chimeric Antigen Receptor T Cell Therapy - Biology of Blood and Marrow Transplantation
![Frontiers | Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies Frontiers | Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies](https://www.frontiersin.org/files/Articles/954235/fimmu-13-954235-HTML-r2/image_m/fimmu-13-954235-g001.jpg)
Frontiers | Combination strategies to optimize the efficacy of chimeric antigen receptor T cell therapy in haematological malignancies
![Frontiers | CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments Frontiers | CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments](https://www.frontiersin.org/files/Articles/925985/fimmu-13-925985-HTML-r1/image_m/fimmu-13-925985-g001.jpg)
Frontiers | CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
![Stem Cell Transplant and CAR T-cell Therapy: When Are They Used for Lymphoma and Multiple Myeloma? | Dana-Farber Cancer Institute Stem Cell Transplant and CAR T-cell Therapy: When Are They Used for Lymphoma and Multiple Myeloma? | Dana-Farber Cancer Institute](https://blog.dana-farber.org/insight/wp-content/uploads/2018/04/CAR-T-Cell-Attack-Art.jpg)
Stem Cell Transplant and CAR T-cell Therapy: When Are They Used for Lymphoma and Multiple Myeloma? | Dana-Farber Cancer Institute
![CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insights - ScienceDirect CAR T-cell therapy in highly aggressive B-cell lymphoma: emerging biological and clinical insights - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497122006589-grabsf1.jpg)